Aparna Narendrula, Jacob Lang, & Elias Mossialos. (2023). Generic cardiology drug prices: The potential benefits of the Marc Cuban cost plus drug company model. Frontiers Media S.A..
Chicago Style (17th ed.) CitationAparna Narendrula, Jacob Lang, and Elias Mossialos. Generic Cardiology Drug Prices: The Potential Benefits of the Marc Cuban Cost Plus Drug Company Model. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationAparna Narendrula, et al. Generic Cardiology Drug Prices: The Potential Benefits of the Marc Cuban Cost Plus Drug Company Model. Frontiers Media S.A., 2023.
Warning: These citations may not always be 100% accurate.